Blog

Understand the impact of the upcoming DSCSA saleable returns verification requirement for both pharma companies and wholesale distributors.

See the results of TraceLink’s FDA pilot project that focused on two workstreams; digital recalls and blockchain with participants from 22 companies…

If you haven’t started receiving transaction documentation (T3) in electronic format, your paperwork could be throwing you out of compliance.

What would it mean for your Life Sciences supply chain business to enable serialization aggregation and support it? Understand the implications.

Find out how many internal resources companies are dedicating to, and how much they're spending on track and trace system validation.

Discover 4 key reasons Cheyenne Regional Medical Center chose a 3rd party solution to streamline their DSCSA compliance.

Review the different approaches healthcare organizations can take to achieve DSCSA compliance.

Get insights into how much serialization will really cost your company. Proven serialization solution providers can help identify additional costs.

Serialization aggregation has the potential to add both complexity and cost for life sciences supply chain businesses. Understand the basics

Insights into the November 27, 2017, FDA draft guidance around grandfathering product under DSCSA.

In May 2018, the FDA published new DSCSA guidance.

Read an interview with ACS PharmaProtect to learn how the German national system works and how it will operate under EU FMD.